[Recommendations for the diagnosis and treatment of Behçet's syndrome in China]

Zhonghua Nei Ke Za Zhi. 2021 Oct 1;60(10):860-867. doi: 10.3760/cma.j.cn112138-20210604-00398.
[Article in Chinese]

Abstract

Behçet's syndrome (BS) is classified among variable vessel vasculitis with unknown etiology and extensively heterogeneous clinical features. It is easily missed or misdiagnosed due to the lack of a specific laboratory diagnosis index. Based on the evidence and guidelines from China and other countries, the Chinese Rheumatology Association developed the standardization of diagnosis and treatment of BS. The purposes are: (1) To standardize the detection and interpretation of key indicators for BS; (2) To standardize rational management for BS patients with topical and systemic organ involvement to reduce complications and improve outcomes.

白塞综合征是一种病因未明的全身慢性血管炎症性疾病,临床表现多样,且缺乏特异性实验室指标,临床误诊和漏诊率较高。中华医学会风湿病学分会在借鉴国内外诊治经验和指南的基础上,制定了本诊疗规范,旨在规范白塞综合征诊断及各系统受累的治疗策略,减少误诊漏诊及严重不良事件的发生,改善患者预后。.

MeSH terms

  • Behcet Syndrome* / diagnosis
  • Behcet Syndrome* / therapy
  • China
  • Humans